Microbix Biosystems, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -19.05% vs 13.51% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -16.67% vs 20.00% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3.40",
          "val2": "4.20",
          "chgp": "-19.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.80",
          "val2": "-0.50",
          "chgp": "-60.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.30",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.40",
          "val2": "-1.20",
          "chgp": "-16.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-373.70%",
          "val2": "-225.00%",
          "chgp": "-14.87%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Sep 2025 is -26.77% vs 53.94% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Sep 2025 is -162.86% vs 0.00% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "18.60",
          "val2": "25.40",
          "chgp": "-26.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.20",
          "val2": "5.50",
          "chgp": "-96.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.00",
          "val2": "0.90",
          "chgp": "11.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.20",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.20",
          "val2": "3.50",
          "chgp": "-162.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-84.80%",
          "val2": "153.80%",
          "chgp": "-23.86%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

3.40

4.20

-19.05%

Operating Profit (PBDIT) excl Other Income

-0.80

-0.50

-60.00%

Interest

0.30

0.30

Exceptional Items

0.00

0.00

Consolidate Net Profit

-1.40

-1.20

-16.67%

Operating Profit Margin (Excl OI)

-373.70%

-225.00%

-14.87%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -19.05% vs 13.51% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is -16.67% vs 20.00% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

18.60

25.40

-26.77%

Operating Profit (PBDIT) excl Other Income

0.20

5.50

-96.36%

Interest

1.00

0.90

11.11%

Exceptional Items

0.00

0.20

-100.00%

Consolidate Net Profit

-2.20

3.50

-162.86%

Operating Profit Margin (Excl OI)

-84.80%

153.80%

-23.86%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Sep 2025 is -26.77% vs 53.94% in Sep 2024

Consolidated Net Profit

YoY Growth in year ended Sep 2025 is -162.86% vs 0.00% in Sep 2024

All Annual Results